Slide

CRITICAL
NEED

Medical care in this country for cancer, heart disease, and bone scans simply cannot be held hostage to the maintenance schedules of a 50‑year‑old reactor in Europe. It is absolutely vital that we act to bring a robust domestic supply of these critical medical isotopes online as soon as possible.

- Rep. Edward J. Markey, U.S. House of
Representatives (hearing remarks)

previous arrow
next arrow

CRITICAL
NEED

Medical care in this country for cancer, heart disease, and bone scans simply cannot be held hostage to the maintenance schedules of a 50‑year‑old reactor in Europe. It is absolutely vital that we act to bring a robust domestic supply of these critical medical isotopes online as soon as possible.

Delivering North America’s First Purpose-Built Medical Isotope Reactor

Introduction

Before

Until recently, nuclear medicine focused exclusively on diagnostics and limited radiopharmaceutical therapy treatments.

Today Forward

But now, breakthroughs in novel, cancer-targeting radiotherapeutics are driving a precision medicine revolution.

Challenges

Radioisotope supply can’t keep pace with medical innovation or projected demand.
No large-scale domestic production in North America. The U.S. depends on insecure global supply chains and aging, inefficient foreign reactors.

SolutionS

Eden Radioisotopes – Privately held U.S. medical isotope producer.

Developing on-shore, purpose-built reactor for isotope production.

Low energy use, high output, and cost-efficient tech ensures secure, sustainable supply.

Positioned to strengthen U.S. medical infrastructure and support the future of precision medicine.